Opus Genetics is trading 5.12% higher at $3.49, with the biotech-sector rally offering possible context; no direct company catalyst was identified.

  • No new company-specific announcement explaining the October 27 move surfaced in the search.
  • XBI rose 2.18% during the regular session; the S&P 500 and Nasdaq were also higher.